Security key
320703309
CALIDI BIOTHERAPEUTICS, INC. - Common stock, par value $0.0001 per share (CLDI)
CUSIP: 320703309
Q3 2024 13F Holders as of 30 Sep 2024
- Type / Class
- Equity / Common stock, par value $0.0001 per share
- Shares outstanding
- 11,128,448
- Total 13F shares
- 318,770
- Share change
- +161,945
- Total reported value
- $363,396
- Price per share
- $1.14
- Number of holders
- 19
- Value change
- +$331,789
- Number of buys
- 18
- Number of sells
- 2
Report period
Q3 2024
Institutions
19
Top holders
10
CLDI full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q4 2024
Previous quarter: Q2 2024
Calidi Biotherapeutics, Inc. SEC filings
Calidi Biotherapeutics, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 320703309
Recent filing periods:
Ownership snapshot
Top shareholders of CLDI - CALIDI BIOTHERAPEUTICS, INC. - Common stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Lead holder
DRIEHAUS CAPITAL MANAGEME...
13D/G signal
—
Evidence rows
50
Latest as of
30 Jun 2024
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| DRIEHAUS CAPITAL MANAGEMENT LLC |
13F
Company
|
0.85%
|
$18,939
94,697 shares
|
— | 30 Jun 2024 |
| MARSHALL WACE, LLP |
13F
Company
|
0.56%
|
$12,373
61,869 shares
|
— | 30 Jun 2024 |
| Polar Asset Management Partners Inc. |
3/4/5
13F
10%+ Owner · Company
|
—
mixed-class rows
|
$4,330,272
412,800 shares
|
— | 19 Oct 2022 |
| First Light Acquisition Group, LLC |
3/4/5
10%+ Owner
|
—
class O/S missing
|
—
1,931,852 shares
|
— | 16 Jun 2023 |
| Stephen Thesing |
3/4/5
Chief Business Officer
|
—
class O/S missing
|
$848,779
471,544 shares
|
— | 12 Sep 2023 |
| Boris Radoslavov Minev |
3/4/5
Interim Chief Medical Officer
|
—
mixed-class rows
|
$764,024
455,818 shares
mixed-class rows
|
— | 17 Jun 2024 |
| Thomas A. Vecchiolla |
3/4/5
Director
|
—
mixed-class rows
|
$657,189
781,459 shares
mixed-class rows
|
— | 21 Dec 2023 |
| Tony T. Kalajian |
3/4/5
Chief Acctg Officer, Int. CFO
|
—
class O/S missing
|
$501,822
278,790 shares
|
— | 12 Sep 2023 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q3 2024
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
19
Shares
318,770
Rows loaded
19
| Investor | Option | Weight % | Change % | Reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* Reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. An asterisk next to the price means the price is likely invalid.
Compare Q3 2024 vs Q2 2024 Across Filers
Q2 2024 holders
2
Q3 2024 holders
19
Holder diff
17
| Investor | Q2 2024 Shares | Q3 2024 Shares | Share Diff | Share Chg % | Q2 2024 value | Q3 2024 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend